cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers cagrisema phase 3 results 2024

US$ 21.93

★★★★★ 4.3 (6 reviews)

US$ 28.37

★★★★★ 4.0 (24 reviews)

US$ 26.80

★★★★★ 4.7 (22 reviews)

US$ 27.14

★★★★★ 4.3 (11 reviews)

US$ 28.33

★★★★★ 4.5 (10 reviews)

US$ 22.32

★★★★★ 4.1 (5 reviews)

US$ 23.83

★★★★★ 4.2 (15 reviews)

US$ 23.51

★★★★★ 4.6 (17 reviews)

US$ 23.55

★★★★★ 4.6 (25 reviews)

US$ 20.33

★★★★★ 4.2 (13 reviews)

US$ 20.63

★★★★★ 4.6 (28 reviews)

US$ 22.12

★★★★★ 4.9 (26 reviews)

US$ 26.38

★★★★★ 5.0 (18 reviews)

US$ 27.21

★★★★★ 4.7 (30 reviews)

US$ 23.88

★★★★★ 4.9 (5 reviews)

US$ 29.08

★★★★★ 4.8 (25 reviews)

US$ 22.66

★★★★★ 4.3 (16 reviews)

US$ 22.19

★★★★★ 4.0 (29 reviews)

US$ 25.36

★★★★★ 4.4 (20 reviews)

US$ 24.69

★★★★★ 4.5 (14 reviews)